Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34621019)

  • 1. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer.
    Gao S; Soares F; Wang S; Wong CC; Chen H; Yang Z; Liu W; Go MYY; Ahmed M; Zeng Y; O'Brien CA; Sung JJY; He HH; Yu J
    Oncogene; 2021 Dec; 40(48):6601-6613. PubMed ID: 34621019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies.
    Giolito MV; Bodoirat S; La Rosa T; Reslinger M; Guardia GDA; Mourtada J; Claret L; Joung A; Galante PAF; Penalva LOF; Plateroti M
    Cell Death Dis; 2024 May; 15(5):306. PubMed ID: 38693105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
    Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
    Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer.
    Wang R; Wei J; Zhang S; Wu X; Guo J; Liu M; Du K; Xu J; Peng L; Lv Z; You W; Xiong Y; Fu Z
    Oncotarget; 2016 Dec; 7(52):86816-86828. PubMed ID: 27894099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance.
    Yoon C; Park DJ; Schmidt B; Thomas NJ; Lee HJ; Kim TS; Janjigian YY; Cohen DJ; Yoon SS
    Clin Cancer Res; 2014 Aug; 20(15):3974-88. PubMed ID: 24947926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antrodia cinnamomea Enhances Chemo-Sensitivity of 5-FU and Suppresses Colon Tumorigenesis and Cancer Stemness via Up-Regulation of Tumor Suppressor miR-142-3p.
    Huang YJ; Yadav VK; Srivastava P; Wu AT; Huynh TT; Wei PL; Huang CF; Huang TH
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31349708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells.
    Leung HW; Ko CH; Yue GG; Herr I; Lau CB
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):185-197. PubMed ID: 29777274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer.
    Chen Q; Song S; Wei S; Liu B; Honjo S; Scott A; Jin J; Ma L; Zhu H; Skinner HD; Johnson RL; Ajani JA
    Oncotarget; 2015 Sep; 6(28):25883-96. PubMed ID: 26317542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
    Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
    Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line.
    Fang DD; Cao J; Jani JP; Tsaparikos K; Blasina A; Kornmann J; Lira ME; Wang J; Jirout Z; Bingham J; Zhu Z; Gu Y; Los G; Hostomsky Z; Vanarsdale T
    Front Med; 2013 Dec; 7(4):462-76. PubMed ID: 23820871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation.
    Boothello RS; Patel NJ; Sharon C; Abdelfadiel EI; Morla S; Brophy DF; Lippman HR; Desai UR; Patel BB
    Mol Cancer Ther; 2019 Jan; 18(1):51-61. PubMed ID: 30337351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.
    Lavitrano M; Ianzano L; Bonomo S; Cialdella A; Cerrito MG; Pisano F; Missaglia C; Giovannoni R; Romano G; McLean CM; Voest EE; D'Amato F; Noli B; Ferri GL; Agostini M; Pucciarelli S; Helin K; Leone BE; Canzonieri V; Grassilli E
    J Pathol; 2020 Feb; 250(2):134-147. PubMed ID: 31518438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
    Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
    J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
    Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
    BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
    Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
    Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin strongly inhibits the growth kinetics of colon cancer stem cell-enriched spheroids by modulating interleukin 4/6-mediated survival signals.
    Kumar S; Raina K; Agarwal C; Agarwal R
    Oncotarget; 2014 Jul; 5(13):4972-89. PubMed ID: 24970802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
    Ghatak S; Hascall VC; Markwald RR; Misra S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy.
    Luraghi P; Bigatto V; Cipriano E; Reato G; Orzan F; Sassi F; De Bacco F; Isella C; Bellomo SE; Medico E; Comoglio PM; Bertotti A; Trusolino L; Boccaccio C
    Clin Cancer Res; 2018 Feb; 24(4):807-820. PubMed ID: 28974546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.